1. The Hippo pathway as a drug target in gastric cancer
   Yiting Qiao et al, 2018, Cancer Letters CrossRef
2. Cetuximab inhibits oral squamous cell carcinoma invasion and metastasis via degradation of epidermal growth factor receptor
   Wei Dai et al, 2014, Journal of Oral Pathology & Medicine CrossRef
3. The role of epidermal growth factor receptor in prognosis and treatment of gastric cancer
   Liu Hong et al, 2014, Expert Review of Gastroenterology & Hepatology CrossRef
4. Amphiregulin enhances cell migration and resistance to doxorubicin in chondrosarcoma cells through the MAPK pathway
   Jui‐Chieh Chen et al, 2018, Molecular Carcinogenesis CrossRef
5. Model-based analysis of response and resistance factors of cetuximab treatment in gastric cancer cell lines
   Elba Raimúndez et al, 2020, PLOS Computational Biology CrossRef
6. Molecular Signaling Pathways Involved in Gastric Cancer Chemoresistance
   Henu Kumar Verma et al, 2020, Theranostics Approaches to Gastric and Colon Cancer CrossRef
7. scInTime: A Computational Method Leveraging Single-Cell Trajectory and Gene Regulatory Networks to Identify Master Regulators of Cellular Differentiation
   Qian Xu et al, 2022, Genes CrossRef
8. MET as resistance factor for afatinib therapy and motility driver in gastric cancer cells
   Karolin Ebert et al, 2019, PLOS ONE CrossRef
9. Inhibition of the JAK2/STAT3 Pathway Reduces Gastric Cancer Growth In Vitro and In Vivo
   Louise M. Judd et al, 2014, PLoS ONE CrossRef
10. KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study
    N C T van Grieken et al, 2013, British Journal of Cancer CrossRef
11. Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines
    Julia Kneissl et al, 2017, Journal of Cancer Research and Clinical Oncology CrossRef
12. Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines
    Karolin Ebert et al, 2020, BMC Cancer CrossRef
13. Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis
    Simone Keller et al, 2017, BMC Cancer CrossRef
14. Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcoma
    Ju-Fang Liu et al, 2015, Oncotarget CrossRef
15. Correlation between Trop2 and amphiregulin coexpression and overall survival in gastric cancer
    Wei Zhao et al, 2017, Cancer Medicine CrossRef
16. cMET as a potential therapeutic target in gastric cancer (Review)
    LISONG TENG et al, 2013, International Journal of Molecular Medicine CrossRef
17. Abnormal amphiregulin expression correlates with gastric cancer prognosis
    Bing Wang et al, 2016, Oncotarget CrossRef
18. Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines
    Simone Keller et al, 2018, Molecular Oncology CrossRef
19. Clinicopathological Significance and Diagnostic Accuracy of c-MET Expression by Immunohistochemistry in Gastric Cancer: A Meta-Analysis
    Jung-Soo Pyo et al, 2016, Journal of Gastric Cancer CrossRef
20. Transforming growth factor alpha promotes osteosarcoma metastasis by ICAM-1 and PI3K/Akt signaling pathway
    Chun-Han Hou et al, 2014, Biochemical Pharmacology CrossRef
21. Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies—the role of HAS2, SHB and HBEGF
    Karolin Ebert et al, 2022, BMC Cancer CrossRef
22. Genetic alterations shaping tumor response to anti-EGFR therapies
    Javier Vaquero et al, 2022, Drug Resistance Updates CrossRef
23. Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer
    Jun Lu et al, 2015, Journal of Translational Medicine CrossRef